Global, regional, and national burden of nonrheumatic calcific aortic valve disease based on GBD study 2021

Baiqiang Wang1,2, Zeyuan Mei1, Hong Yang3

  • 1State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

Scientific Reports
|August 12, 2025
PubMed

Insights

Calcific aortic valve disease (CAVD) cases are rising globally, with increasing prevalence and incidence but declining mortality rates. Targeted prevention strategies are crucial due to age, sex, and regional disparities in CAVD burden.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Calcific aortic valve disease (CAVD) is a leading nonrheumatic valvular heart condition.
  • It imposes a significant global health burden, necessitating an understanding of its trends.

Purpose of the Study:

  • To analyze global CAVD trends from 1992 to 2021.
  • To provide insights for developing effective CAVD prevention strategies.
  • To project future CAVD trends through 2036.

Main Methods:

  • Utilized Global Burden of Disease Study 2021 (GBD 2021) data.
  • Analyzed age-standardized prevalence, incidence, mortality, and DALYs.
  • Examined age- and sex-specific patterns, contributing factors, and regional disparities.

Main Results:

  • Global CAVD cases increased from 4.97 to 13.32 million (1992-2021).
  • Age-standardized prevalence and incidence rates rose, while mortality and DALY rates declined.
  • CAVD burden increased with age, showed higher rates in males, but higher mortality in females over 85.
  • Burden correlated positively with Sociodemographic Index (SDI), with widening gaps between High and Low SDI regions.

Conclusions:

  • Population growth and aging are key drivers of increasing CAVD burden.
  • Epidemiological transitions reduced mortality/DALYs in High SDI regions.
  • Projections indicate declining rates in High/High-middle SDI regions by 2036, but rising prevalence/incidence elsewhere.
  • Targeted strategies are needed to address demographic and regional disparities in CAVD.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40